ARCHIVES

DCT Board Approves Recompetition Of Drug Development Contracts

This article is from The Cancer Letter archive.

Vol. 19 No. 26 | June 25, 1993

Download PDF Visit The Full Archive

Related Articles

NCI National Lab’s Budget to Grow Over Its $299.2 Million FY2013 Level

February 28, 2014

Margaret Edwards, 80, Cancer Education Pioneer, Dead

September 16, 1994

Platinum-Free Break Enhances Therapy After First Relapse In Ovarian Cancer

March 28, 2003

Weekly Paclitaxel, Carboplatin Safer For Advanced Lung Cancer, Study Finds

August 31, 2001

ACS Did Not Sign Bumpers Letter

May 1, 1992

‘Helping Smokers Quit’ Program Launched By NCI, Pharmacist Group

June 27, 1986